Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism

International Journal of Obesity

Volumn 35, Issue 8, 2011, Pages 1019-1030

  Kim, M H ^a   Park, J S ^a   Jung, J W ^a   Byun, K W ^b   Kang, K S ^a   Lee, Y S ^a  

^a Seoul National University   (South Korea)

^b Bucheon University   (South Korea)

Author keywords

adipocyte metabolism; daidzein; hepatic de novo lipogenesis; insulin signaling; non alcoholic fatty liver disease

Indexed keywords

ADIPONECTIN; BINDING PROTEIN; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; DAIDZEIN; GHRELIN; GLUCOSE; INSULIN; LEPTIN; LIPID; LIVER X RECEPTOR BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INHIBITION KINETICS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPOGENESIS; LIVER PROTECTION; MALE; METABOLIC REGULATION; MICROARRAY ANALYSIS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; UPREGULATION;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DIET; FATTY LIVER; GENE EXPRESSION PROFILING; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; LIPOGENESIS; MICE; MICE, INBRED C57BL; PHYTOESTROGENS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 80051598136     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.256     Document Type: Article

References (63)

1. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121. (Pubitemid 41002048)
2. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-1432. (Pubitemid 27339358)
3. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192. (Pubitemid 32246672)
4. Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 2005; 22: 1354-1358. (Pubitemid 41391311)
5. Ikejima K, Okumura K, Kon K, Takei Y, Sato N. Role of adipocytokines in hepatic fibrogenesis. J Gastroenterol Hepatol 2007; 22(Suppl 1): S87-S92. (Pubitemid 46849004)
6. Uyeda K, Yamashita H, Kawaguchi T. Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol 2002; 63: 2075-2080. (Pubitemid 34756672)
7. Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006; 55: 2159-2170. (Pubitemid 44743612)
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808. (Pubitemid 38063703)
9. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signalrelated kinase and elevation of intracellular cAMP. Diabetes 2002; 51: 2929-2935.
10. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183-190. (Pubitemid 40321354)
11. Lee YM, Choi JS, Kim MH, Jung MH, Lee YS, Song J. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition 2006; 22: 956-964. (Pubitemid 44234007)
12. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CW. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003; 278: 962-967. (Pubitemid 36790772)
13. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003; 144: 3315-3320. (Pubitemid 36904405)
14. Shutt D, Braden A. The significance of equol in relation to the oestrogenic responses in sheep ingesting clover with a high formononetin content. Aust J Agric Res 1968; 19: 545-553.
15. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 1998; 356: 133-141. (Pubitemid 28387717)
16. Reeves PG, Nielsen FH, Fahey Jr GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-1951. (Pubitemid 23342492)
17. Frings CS, Fendley TW, Dunn RT, Queen CA. Improved determination of total serum lipids by the sulfo-phospho-vanillin reaction. Clin Chem 1972; 18: 673-674.
18. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
19. Ashwell M, Priest P, Bondoux M, Sowter C, McPherson CK. Human fat cell sizing-a quick, simple method. J Lipid Res 1976; 17: 190-192.
20. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-193. (Pubitemid 36181903)
21. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, Lee JK. Localpooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 2003; 19: 1945-1951. (Pubitemid 37322339)
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
23. Thomas BF, Zeisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM et al. Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 2001; 760: 191-205. (Pubitemid 32727241)
24. Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 2004; 101: 11245-11250. (Pubitemid 39038332)
25. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci USA 2001; 98: 13710-13715. (Pubitemid 33115963)
26. Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck J et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob. Mice Diabetes 2006; 55: 2159-2170. (Pubitemid 44743612)
27. Chen HW, Yang JJ, Tsai CW,Wu JJ, Sheen LY, Ou CC et al. Dietary fat and garlic oil independently regulate hepatic cytochrome p(450) 2B1 and the placental form of glutathione S-transferase expression in rats. J Nutr 2001; 131: 1438-1443.
28. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 2004; 40: 177-184. (Pubitemid 38868936)
29. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209-1210. (Pubitemid 23331713)
30. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 1998; 67: 867-872. (Pubitemid 28196660)
31. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 1997; 350: 23-27.
32. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. Faseb J 2005; 19: 136-138. (Pubitemid 40069943)
33. Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 2002; 366: 377-391. (Pubitemid 35001682)
34. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 2002; 277: 9520-9528. (Pubitemid 34953041)
35. Denechaud PD, Dentin R, Girard J, Postic C. Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett 2008; 582: 68-73. (Pubitemid 350297238)
36. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 2007; 282: 743-751. (Pubitemid 47076632)
37. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K. Mechanism for fatty acid 'sparing' effect on glucose-induced transcription: regulation of carbohydrate-responsive elementbinding protein by AMP-activated protein kinase. J Biol Chem 2002; 277: 3829-3835. (Pubitemid 34968632)
38. Burke SJ, Collier JJ, Scott DK. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. FASEB J 2009; 23: 2855-2865.
39. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806. (Pubitemid 34000783)
40. Lee YH, Giraud J, Davis RJ, White MF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 2003; 278: 2896-2902. (Pubitemid 36801194)
41. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 2002; 277: 48115-48121. (Pubitemid 35470759)
42. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 1998; 273: 5678-5684. (Pubitemid 28124039)
43. Hansmannel F, Clemencet MC, Le Jossic-Corcos C, Osumi T, Latruffe N, Nicolas-Frances V. Functional characterization of a peroxisome proliferator response-element located in the intron 3 of rat peroxisomal thiolase B gene. Biochem Biophys Res Commun 2003; 311: 149-155. (Pubitemid 37297899)
44. Louet JF, Chatelain F, Decaux JF, Park EA, Kohl C, Pineau T et al. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway. Biochem J 2001; 354: 189-197. (Pubitemid 32183459)
45. Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001; 21: 193-230. (Pubitemid 32695270)
46. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli Wet al. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 1995; 270: 19269-19276.
47. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 50 flanking sequence of the rat acyl CoA oxidase gene. Embo J 1992; 11: 433-439.
48. Kim S, Sohn I, Lee YS, Lee YS. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 2005; 135: 33-41. (Pubitemid 40094317)
49. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100. (Pubitemid 38056380)
50. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003; 125: 1796-1807. (Pubitemid 37500444)
51. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-1295. (Pubitemid 35373562)
52. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301.
53. Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM. Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Endocrinology 2006; 147: 1480-1487. (Pubitemid 43244383)
54. Gallardo N, Bonzon-Kulichenko E, Fernandez-Agullo T, Molto E, Gomez-Alonso S, Blanco P et al. Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 2007; 148: 5604-5610. (Pubitemid 350146140)
55. Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulations in obesityrelated murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 2000; 31: 633-640. (Pubitemid 30118631)
56. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL et al. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289: 950-953. (Pubitemid 30659947)
57. Zhao J, Yue W, Zhu MJ, Sreejayan N, Du M. AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of betacatenin at Ser 552. Biochem Biophys Res Commun 2010; 395: 146-151.
58. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti Met al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001; 86: 5083-5086. (Pubitemid 33020569)
59. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002; 146: 241-244. (Pubitemid 34162918)
60. Choi I, Kim Y, Park Y, Seog H, Choi H. Anti-obesity activities of fermented soygerm isoflavones by Bifidobacterium breve. Biofactors 2007; 29: 105-112. (Pubitemid 47219944)
61. Mills E, Kuhn CM, Feinglos MN, Surwit R. Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. Am J Physiol 1993; 264: R73-R78. (Pubitemid 23053529)
62. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995; 44: 645-651.
63. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988; 37: 1163-1167. (Pubitemid 19035045)